The most common side effects of AUSTEDO in people with tardive dyskinesia include inflammation of the nose and throat (nasopharyngitis) and problems sleeping (insomnia). The most common side …

AUSTEDO XR ® (deutetrabenazine) extended-release tablets and AUSTEDO ® (deutetrabenazine) tablets are indicated in adults for the treatment of chorea associated with Huntington’s disease and …

Aug 20, 2025 · Austedo is used to treat the involuntary movements of Huntington's disease and tardive dyskinesia (TD). Includes Austedo side effects, dosage, uses, interactions, and more

The dose of deutetrabenazine (Austedo) is determined individually for each patient based on reduction of chorea or tardive dyskinesia and tolerability. The package insert contains specific dosing …

Sep 21, 2025 · The most common adverse reactions for AUSTEDO (4% and greater than placebo) in controlled clinical studies in patients with tardive dyskinesia were nasopharyngitis and insomnia.

Jul 16, 2024 · Austedo (aw-STED-oh) was approved in 2017 and is the first medicine approved to treat both tardive dyskinesia and chorea caused by Huntington’s disease.

Dec 17, 2025 · Akathisia and tardive dyskinesia are medication-related movement disorders with distinct causes and treatments. Learn the signs and risks.

May 30, 2024 · Key Takeaways Deutetrabenazine (Austedo XR) is now available as a once-daily, extended-release tablet for tardive dyskinesia and Huntington disease chorea, enhancing dosing …

May 30, 2024 · The FDA has approved Austedo XR as a once-daily pill treatment option for tardive dyskinesia and Huntington disease chorea control.

Mar 5, 2024 · Treatments for tardive dyskinesia include deutetrabenazine (Austedo, Austedo XR), valbenzaine (Ingrezza), tetrabenazine (Xenazine), amantadine, vitamin B6 (pyridoxine) and pyridoxal …